AGP Picks
View all

Africa News Guide
Provided by AGP

Africa News Guide: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Guide.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 4, 2026

DEEP SEA MINERALS CORP. FILES FORM F-10 REGISTRATION STATEMENT WITH U.S. SECURITIES AND EXCHANGE COMMISSION BECOMING A U.S. REPORTING COMPANY
Aug. 4, 2026

DEEP SEA MINERALS CORP. FILES FORM F-10 REGISTRATION STATEMENT WITH U.S. SECURITIES AND EXCHANGE COMMISSION BECOMING A U.S. REPORTING COMPANY

Indeterminate GlobeNewswire
NIOB cuts target pegmatite in all Bardy holes
Aug. 4, 2026

NIOB cuts target pegmatite in all Bardy holes

Indeterminate GlobeNewswire
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 
Aug. 4, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
Aug. 4, 2026

Rhythm Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire
CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement
Aug. 4, 2026

CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement

Indeterminate GlobeNewswire
Lisata Therapeutics Provides Update Following Termination of Merger Agreement
Aug. 4, 2026

Lisata Therapeutics Provides Update Following Termination of Merger Agreement

Indeterminate GlobeNewswire
Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug. 4, 2026

Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug. 4, 2026

Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity
Aug. 4, 2026

Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity

Indeterminate GlobeNewswire
MEXC Ranks No. 1 in Near-Touch BTC, ETH and Silver Futures Depth, TokenInsight's July Liquidity Report Shows
Aug. 4, 2026

MEXC Ranks No. 1 in Near-Touch BTC, ETH and Silver Futures Depth, TokenInsight's July Liquidity Report Shows

Indeterminate GlobeNewswire
CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB)
Aug. 4, 2026

CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB)

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Africa News Guide

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.